Thar Pharmaceuticals

Grunenthal snags a PhIII-ready orphan drug in Thar Pharma buyout
Endpoints
Thu, 11/17/16 - 09:29 am
Grunenthal
Thar Pharmaceuticals
T121
orphan drugs
Thar Pharmaceuticals hopes to raise $50M in IPO
BioPharma Dive
Wed, 08/24/16 - 10:44 am
Thar Pharmaceuticals
IPOs
T121